Ncardia has launched a human-derived microglia cell model, called Ncyte Microglia, that the company says may help advance research in Parkinson’s disease and other neurodegenerative conditions — and which may be a tool in the development of new therapies. Microglia are resident immune cells in the brain that…
Parkinson’s disease patients saw an average increase of more than four hours in the duration of their symptom control, without the presence of dyskinesia, with a consistent supply of A-dopamine directly to their brain, according to a small Phase 1/2 clinical study. DIVE-I (NCT04332276)Â tested how safe A-dopamine, a…
Creative arts therapy, or an expressive therapeutic approach that engages people in various creative activities, can reduce anxiety in individuals with Parkinson’s disease and improve their well-being — while potentially lessening their need for healthcare services — according to the results of a small pilot study conducted in Europe.
Several promising strategies for developing therapeutics capable of crossing or bypassing the blood-brain barrier (BBB) offer potential for treating neurological conditions like Parkinson’s disease, but more work is needed to establish their benefits in clinical trials, a review study suggests. Strategies such as direct brain delivery, focused ultrasound, and…
Biotin (vitamin B7) supplementation may offer protection against manganese-induced brain cell damage, according to a recent study. Manganese is a naturally occurring metal that can cause manganism, a condition characterized by parkinsonism-like symptoms, such as tremors and cognitive issues. In the study led by Souvarish Sarkar, PhD, an assistant…
Researchers at the University of Cambridge in the U.K. are developing brain implants using small clusters of lab-grown cells in combination with electrical impulses to rebuild brain circuits worn down in Parkinson’s disease. “Our ultimate goal is to create precise brain therapies that can restore normal brain function in…
Treatment with the anti-seizure medication levetiracetam led to a worsening of Parkinson’s disease symptoms for a woman in Saudi Arabia, according to a case report. The woman was given levetiracetam to prevent seizures after she fell and hit her head, but she soon after experienced deteriorating neurological and motor…
Levels of a retrovirus that entered the human genome via infections millions of years ago — an endogenous retrovirus called HERV-K that is still part of a person’s DNA — were lower in people with Parkinson’s disease and linked to more severe symptoms and longer disease duration, a study…
The European Medicines Agency (EMA), which evaluates the safety and efficacy of new drugs in the European Union, has waived a requirement that would have had Irlab Therapeutics conducting clinical trials testing mesdopetam — its therapy candidate for levodopa-induced dyskinesia, or uncontrolled, involuntary movements common in Parkinson’s disease…
Parkinson’s disease research and care should address disparities by sex and gender in patients’ symptoms, treatment responses, and disease progression, scientists across Europe and North America state in a commentary. While sex refers to assigned biological differences between males and females, gender refers to how a person identifies, affecting…
Get regular updates to your inbox.
